Related Experiment Video
Updated: Sep 30, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Hypoxia responsive phytonanotheranostics: A novel paradigm towards fighting cancer
Sarbari Acharya1, Ranjita Misra2
1School of Applied Sciences, Kalinga Institute of Industrial Technology, Bhubaneswar, Odisha, India.
Phytomedicine incorporated into nanoparticles offers a new approach for hypoxia therapy in cancer. This review explores smart phytonanotheranostics for targeted cancer treatment and monitoring in hypoxic environments.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Hypoxia significantly increases tumor aggressiveness and reduces anticancer therapy effectiveness.
- Phytomedicine, despite its therapeutic potential, faces limitations in conventional delivery.
- Nanoparticle-based drug delivery systems offer a promising avenue for overcoming these challenges.
Purpose of the Study:
- To review the development and application of smart stimuli-responsive phytonanotherapeutics for hypoxia-driven cancer.
- To highlight the potential of phytonanomedicine and phytonanotheranostics in managing hypoxic tumors.
- To identify research gaps and encourage future studies in this emerging field.
Main Methods:
- Literature review focusing on stimuli-responsive nanoparticles, phytomedicine, and hypoxia.
- Analysis of current research on phytonanomedicine and phytonanotheranostics for cancer therapy.
- Synthesis of information on smart nanotheranostics tailored for the tumor microenvironment.
Main Results:
- Phytonanomedicine and phytonanotheranostics show potential for targeted drug delivery and improved cancer management in hypoxic conditions.
- Smart nanoparticles offer controlled, on-demand drug release based on internal or external stimuli.
- Limited studies currently exist on tailor-made nanotheranostics within the hypoxic tumor microenvironment.
Conclusions:
- Smart stimuli-responsive phytonanotherapeutics represent a novel strategy for enhancing cancer treatment efficacy in hypoxic tumors.
- Further research is needed to fully explore the potential of these advanced nanomedicines.
- This review consolidates current knowledge to guide future investigations in phytonanotheranostics for oncology.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

